Table II.
CVB1 interaction with soluble human CAR and DAF evaluated by reduction plaque assays.
Virus | +hCAR | +hDAF |
---|---|---|
| ||
CVB1N | 2 log reductions* | 1 log reductions* |
CVB1Nm | 2 log reductions* | 0 log reductions |
CVB3 | 2 log reductions* | 0 log reductions |
P<0.05; hCAR (human coxsackievirus-adenovirus receptor); hDAF (human decay-accelerating factor).